In the past 52-week period, shares of Aptevo Therapeutics Inc. (NASDAQ:APVO) have moved within the range of $1.15 to $3.85. On the stock’s most recent trading day, the company’s shares ended the regular session at $3.45, which is 10.39% higher than its 52-week high.
Aptevo Therapeutics Inc. (APVO) has demonstrated a 20-day simple moving average (SMA) of 18.45%, and a 50-day SMA of 31.55%. This public company’s current market capitalization stands at $73.24 million.Analyzing Consensus Estimates, Sales Revenue and Net Income
Understanding Wall Street analyst’s enthusiasm for a particular stock is crucial when considering entering a position. According to the latest data, the consensus recommendation for Aptevo Therapeutics Inc. (APVO) is Outperform.
When it comes to sales data, public companies usually post revenue and earnings that are either higher or lower than the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Aptevo Therapeutics Inc. (APVO) delivered a 38.28% surprise with its net revenue. Sales reached $0.01 billion during the three-month period, compared to the average analyst estimate of $0.01 billion.
Meanwhile, during the same quarter Aptevo Therapeutics Inc. (APVO) delivered a 21.33% earnings surprise. Net earnings for the quarter were posted at $1.77 per share, whereas Wall Street had forecast $2.25 per share.Ownership at Aptevo Therapeutics Inc. (APVO), According to Most Recent SEC Filings
A public company’s latest 13F filings tell investors important details about institutional ownership. Aptevo Therapeutics Inc. (APVO) has 0 billion shares outstanding currently, 32.15% of which belong to institutional investors. Those institutional holdings amount to $0.02 billion.
Additionally, according to the most recent 13F filing from Aptevo Therapeutics Inc. (APVO), there were 5 new positions totaling 148,890 shares of the company’s stock. There were 19 sold out positions, on the other hand, totaling 820,127 shares.Short, Medium and Long Term Indicators
Examining a stock’s average volume in the short, medium and long term is useful to understand trading activity and investor sentiment. Aptevo Therapeutics Inc. (APVO) has had a 20-day average volume of 306,310 shares, with an average of 100% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 724,812 shares, with an average of 100% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 600,677 shares with 100% of long-term indicators pointing to Buy.